REN and endothelial dysfunction: In an additional approach to explore the role of RAAS activation in vascular complications to T2D we analyzed if ongoing treatment with RAAS inhibitors (e.g. ACE inhibitors ARBs or renin inhibitors) was associated with any difference in markers of atherosclerosis, arterial stiffness and endothelial dysfunction.